av/unicycive-therapeutics--big.svg

COM:UNICYCIVE

Unicycive

  • Stock

Last Close

0.53

22/11 21:00

Market Cap

41.21M

Beta: -

Volume Today

841.15K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
951K
-
675K
29.02%
cost of revenue
284K
-
gross profit
951K
-
391K
58.89%
selling and marketing expenses
-284K
-
general and administrative expenses
1.17M
-
1.00M
13.96%
2.90M
188.26%
6.57M
126.68%
8.55M
30.15%
selling general and administrative expenses
1.17M
-
1.00M
13.96%
2.90M
188.26%
6.57M
126.68%
8.26M
25.83%
research and development expenses
795K
-
1.01M
27.67%
6.08M
499.01%
12.44M
104.54%
12.90M
3.75%
other expenses
cost and expenses
1.96M
-
2.02M
2.90%
8.98M
344.41%
19.00M
111.69%
21.45M
12.87%
operating expenses
1.96M
-
2.02M
2.90%
8.98M
344.41%
19.00M
111.69%
21.16M
11.38%
interest expense
139K
-
244K
75.54%
628K
157.38%
6K
99.04%
-82K
1,466.67%
ebitda
-1.96M
-
-2.02M
2.90%
-8.98M
344.41%
-18.05M
101.09%
-20.49M
13.51%
operating income
-1.96M
-
-2.02M
2.90%
-8.98M
344.41%
-18.05M
101.09%
-20.77M
15.08%
depreciation and amortization
13K
-
161K
1,138.46%
284K
76.40%
total other income expenses net
-202K
-
-244K
20.79%
-1.04M
326.23%
-6K
99.42%
-9.77M
162,733.33%
income before tax
-2.17M
-
-2.26M
4.57%
-10.02M
342.45%
-18.06M
80.27%
-30.54M
69.14%
income tax expense
139K
-
244K
75.54%
615K
152.05%
6K
99.02%
net income
-2.30M
-
-2.51M
8.85%
-10.63M
323.92%
-18.06M
69.90%
-30.54M
69.09%
weighted average shs out
14.50M
-
8.58M
40.84%
11.68M
36.14%
15.06M
28.96%
24.54M
62.98%
weighted average shs out dil
14.50M
-
8.58M
40.84%
11.68M
36.14%
15.06M
28.96%
24.54M
62.98%
eps
-0.16
-
-0.29
81.25%
-0.91
213.79%
-1.20
31.87%
-1.24
3.33%
epsdiluted
-0.16
-
-0.29
81.25%
-0.91
213.79%
-1.20
31.87%
-1.24
3.33%

All numbers in (except ratios and percentages)